These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 35311353)
1. Parental understanding and attitudes following pharmacogenomic testing for pediatric neuropsychiatric patients. Berrios C; Sadaro SK; Sandritter T; Wagner JA; Soden S; Black B; Abdel-Rahman S Pharmacogenomics; 2022 Apr; 23(6):345-354. PubMed ID: 35311353 [No Abstract] [Full Text] [Related]
2. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043 [TBL] [Abstract][Full Text] [Related]
3. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377 [TBL] [Abstract][Full Text] [Related]
4. A clinician's guide for counseling patients on results of a multigene pharmacogenomic panel. Ho TT; Bell G; Gammal RS; Gregornik D; Wake DT; Dunnenberger HM Am J Health Syst Pharm; 2022 Sep; 79(19):1634-1644. PubMed ID: 35876085 [TBL] [Abstract][Full Text] [Related]
6. Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing. Drozda K; Pacanowski MA Pharmacotherapy; 2017 Sep; 37(9):1000-1004. PubMed ID: 28605049 [TBL] [Abstract][Full Text] [Related]
7. Patient insights on features of an effective pharmacogenomics patient portal. Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129 [TBL] [Abstract][Full Text] [Related]
8. The challenges of implementing pharmacogenomic testing in the clinic. Moyer AM; Caraballo PJ Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250 [TBL] [Abstract][Full Text] [Related]
9. Precision medicine from a citizen perspective: a survey of public attitudes towards pharmacogenomics in Flanders. Edris A; Callier E; Lahousse L BMC Med Genomics; 2022 Sep; 15(Suppl 3):193. PubMed ID: 36096833 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals. Pearce A; Terrill B; Alffenaar JW; Patanwala AE; Kummerfeld S; Day R; Young MA; Stocker SL Intern Med J; 2022 Jul; 52(7):1135-1143. PubMed ID: 35191159 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients. Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514 [No Abstract] [Full Text] [Related]
12. Community pharmacists' educational needs for implementing clinical pharmacogenomic services. Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787 [TBL] [Abstract][Full Text] [Related]
13. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine. Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145 [TBL] [Abstract][Full Text] [Related]
14. Primary care physician experiences with integrated pharmacogenomic testing in a community health system. Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567 [TBL] [Abstract][Full Text] [Related]
15. Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation. Lee YM; McKillip RP; Borden BA; Klammer CE; Ratain MJ; O'Donnell PH Pharmacogenet Genomics; 2017 May; 27(5):179-189. PubMed ID: 28267054 [TBL] [Abstract][Full Text] [Related]
16. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository. Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152 [TBL] [Abstract][Full Text] [Related]
19. Attitudes toward pharmacogenetics in patients undergoing Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913 [TBL] [Abstract][Full Text] [Related]
20. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population. Lee YM; Manzoor BS; Cavallari LH; Nutescu EA Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]